Advanced search
Start date
Betweenand

Adhesion to antiretroviral therapy by individuals with HIV/AIDS attended at an institution in the interior of São Paulo

Grant number: 13/17888-4
Support type:Scholarships in Brazil - Scientific Initiation
Effective date (Start): February 01, 2014
Effective date (End): January 31, 2015
Field of knowledge:Health Sciences - Nursing - Infectious Diseases Nursing
Principal researcher:Renata Karina Reis
Grantee:Inaiê Vasconcelos Chiló
Home Institution: Escola de Enfermagem de Ribeirão Preto (EERP). Universidade de São Paulo (USP). Ribeirão Preto , SP, Brazil

Abstract

As a result of scientific and technological advances of the past decade, AIDS is now considered as a chronic disease. The great benefit generated by the use of antiretroviral therapy is the prolongation of survival and reduction in mortality, however, the adverse effects associated with this therapy may cause changes in quality of life. Such advances, however, are faced with new challenges today, among them stand adherence to antiretroviral therapy, as its use must be continuous and duradouro.Este study aims to assess adherence to antiretroviral therapy for people living with HIV / AIDS, using the CEAT-HIV. It is an analytical, cross-sectional, which will be held in services specializing in the care of people living with HIV / AIDS, in Ribeirão Preto-SP. For data collection will be used oo CEAT-HIV, as well as a tool for the characterization of participants. This project aims to contribute to the advancement of knowledge about the sociodemographic, clinical, epidemiological, and adherence to antiretroviral therapy for people living with HIV / AIDS and possible improvement actions / interventions in the comprehensive health care of these individuals.

News published in Agência FAPESP Newsletter about the scholarship:
Articles published in other media outlets (0 total):
More itemsLess items
VEICULO: TITULO (DATA)
VEICULO: TITULO (DATA)

Please report errors in scientific publications list by writing to: cdi@fapesp.br.